Impact of Orally Administered Microcapsules on Gastrointestinal Microbial Flora: In-Vitro Investigation Using Computer Controlled Dynamic Human Gastrointestinal Model

REFERENCES

• Chandy, T., Mooradian, D.L., Rao, G.H.R. (1998). Chitosan polyethylene glycol alginate microcapsules for oral delivery of hirudin. Journal of Applied Polymer Science 70: 2143–2153.
   Web of Science ®Google Scholar
• Chandy, T., Mooradian, D.L., Rao, G.H.R. (1998). Chitosan polyethylene glycol alginate microcapsules for oral delivery of hirudin. Journal of Applied Polymer Science 70: 2143–2153.
   Web of Science ®Google Scholar
• Chang, T.M.S. (1964). Semipermeable microcapsules. Science 146: 524–525.
   PubMed Web of Science ®Google Scholar
• Chang, T.M. (2005). Therapeutic applications of polymeric artificial cells. Nat. Rev. Drug Discov. 4: 221–235.
   PubMed Web of Science ®Google Scholar
• O'Loughlin, J.A., Bruder, J.M., Lysaght, M.J. (2004). Degradation of low molecular weight uremic solutes by oral delivery of encapsulated enzymes. ASAIO J. 50: 253–260.
   PubMedGoogle Scholar
• Chang, T.M. (2004). Artificial cells for cell and organ replacements. Artif. Organs 28: 265–270.
   PubMed Web of Science ®Google Scholar
• Orive, G., Gascon, A.R., Hernandez, R.M., Igartua, M., Pedraz, J.L. (2003). Cell microencapsulation technology for biomedical purposes: novel insights and challenges. Trends in Pharmacological Sciences 24: 207–210.
   PubMed Web of Science ®Google Scholar
• Orive, G. , et al. (2004). History, challenges and perspectives of cell microencapsulation. Trends in Biotechnology 22: 87–92.
   PubMed Web of Science ®Google Scholar
• Orive, G. , et al. (2003). Cell encapsulation: promise and progress. Nat. Med. 9: 104–107.
   PubMed Web of Science ®Google Scholar
• Lee, C.H., Wang, Y.J., Kuo, S.M., Chang, S.J. (2004). Microencapsulation of parathyroid tissue with photosensitive poly(L-lysine) and short chain alginate-co-MPEG. Artif. Organs 28: 537–542.
   PubMedGoogle Scholar
• Lee, C.S., Chu, I.M. (1997). Characterization of modified alginate-poly-L-lysine microcapsules. Artif. Organs 21: 1002–1006.
   PubMedGoogle Scholar
• Strand, B.L., Morch, Y.A., Syvertsen, K.R., Espevik, T., Skjak-Braek, G. (2003). Microcapsules made by enzymatically tailored alginate. Journal of Biomedical Materials Research Part A 64A: 540–550.
   Google Scholar
• Prakash, S., Jones, M.L. (2005). Artificial cell therapy: new strategies for the therapeutic delivery of live bacteria. J. Biomed. Biotechnol. 2005: 44–56.
   PubMedGoogle Scholar
• Prakash, S., Bhathena, J. (2005). Live bacterial cells as orally delivered therapeutics. Expert Opin. Biol. Ther. 5: 1281–1301.
   PubMed Web of Science ®Google Scholar
• Wei, O.Y. , et al. (2004). Artificial cell microcapsule for oral delivery of live bacterial cells for therapy: Design, preparation, and in-vitro characterization. Journal of Pharmacy and Pharmaceutical Sciences 7: 315–324.
   PubMedGoogle Scholar
• Molly, K., Van de Woestyne, M., Vestraete, W. (1993). Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl. Microbiol. Biotechnol. 39: 254–258.
   PubMed Web of Science ®Google Scholar
• Molly, K., Van de Woestyne, M., De Smet, I., Verstraete, W. (1994). Validation of the simulator of the human intestinal microbial ecosystem (SHIME) reactor using microorganism-associated activities. Microbial Ecology in Health and Disease 7: 191–200.
   Web of Science ®Google Scholar
• Chen, H. , et al. (2005). In-vitro analysis of APA microcapsules for oral delivery of live bacterial cells. J Microencapsul. 22: 539–547.
   PubMed Web of Science ®Google Scholar
• Berg, J.O., Nord, C.E., Wadstrom, T. (1978). Formation of glycosidases in batch and continuous culture of Bacteroides fragilis. Appl. Environ. Microbiol. 35: 269–273.
   PubMed Web of Science ®Google Scholar
• Chang, P.L. (1999). Encapsulation for somatic gene therapy. Bioartificial Organs Ii: Technology, Medicine, and Materials 875: 146–158.
   Google Scholar
• Chang, T.M., Prakash, S. (1997). Artificial cells for bioencapsulation of cells and genetically engineered E. coli for cell therapy, gene therapy, and removal of urea and ammonia. Methods Mol. Biol. 63: 343–358.
   PubMedGoogle Scholar
• Chang, T.M. (1998). Artificial cells with emphasis on cell encapsulation of genetically engineered cells. Artif. Organs 22: 958–965.
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S., Prakash, S. (1998). Therapeutic uses of microencapsulated genetically engineered cells. Molecular Medicine Today 4: 221–227.
   PubMedGoogle Scholar
• Chen, L.G. , et al. (2004). Encapsulated transgene cells attenuate hypertension, cardiac hypertrophy and enhance renal function in Goldblatt hypertensive rats. J. Gene Med. 6: 786–797.
   PubMed Web of Science ®Google Scholar
• Kailasapathy, K. (2002). Microencapsulation of probiotic bacteria: technology and potential applications. Curr. Issues Intest. Microbiol. 3: 39–48.
   PubMedGoogle Scholar
• Lohr, J.M., Saller, R., Salmons, B., Gunzburg, W.H. (2002). Microencapsulation of genetically engineered cells for cancer therapy. Methods Enzymol. 346: 603–618.
   PubMed Web of Science ®Google Scholar
• Prakash, S., Chang, T.M. (1999). Artificial cell microcapsules containing genetically engineered E. coli DH5 cells for in-vitro lowering of plasma potassium, phosphate, magnesium, sodium, chloride, uric acid, cholesterol, and creatinine: a preliminary report. Artif. Cells Blood Substit. Immobil. Biotechnol. 27: 475–481.
   PubMed Web of Science ®Google Scholar
• Shoichet, M.S., Winn, S.R. (2000). Cell delivery to the central nervous system. Adv. Drug Deliv. Rev. 42: 81–102.
   PubMed Web of Science ®Google Scholar
• Soon-Shiong, P. (1999). Treatment of type I diabetes using encapsulated islets. Advanced Drug Delivery Reviews 35: 259–270.
   PubMed Web of Science ®Google Scholar
• Yu, B., Chang, T.M. (2004). Effects of long-term oral administration of polymeric microcapsules containing tyrosinase on maintaining decreased systemic tyrosine levels in rats. J. Pharm. Sci. 93: 831–837.
   PubMedGoogle Scholar
• Chandy, T., Mooradian, D.L., Rao, G.H.R. (1998). Chitosan polyethylene glycol alginate microcapsules for oral delivery of hirudin. Journal of Applied Polymer Science 70: 2143–2153.
   Web of Science ®Google Scholar
• Mehta, N.M. (2004). Oral delivery and recombinant production of peptide hormones Part I: Making oral delivery possible - Enteric-coated capsules or tablets with additional excipients enable intestinal delivery. Biopharm International, The Applied Technologies of Biopharmaceutical Development 17: 38–43.
   Google Scholar
• O'Loughlin, J.A., Bruder, J.M., Lysaght, M.J. (2004). Degradation of low molecular weight uremic solutes by oral delivery of encapsulated enzymes. ASAIO J. 50: 253–260.
   PubMedGoogle Scholar
• Ashford, M., Fell, J., Attwood, D., Sharma, H., Woodhead, P. (1993). An evaluation of pectin as a carrier for drug targeting to the colon. Journal of Controlled Release 26: 213–220.
   Web of Science ®Google Scholar
• Liu, P., Krishnan, T.R. (1999). Alginate-pectin-poly-L-lysine particulate as a potential controlled release formulation. Journal of Pharmacy and Pharmacology 51: 141–149.
   PubMed Web of Science ®Google Scholar
• Alander, M. , et al. (1999). The effect of probiotic strains on the microbiota of the Simulator of the Human Intestinal Microbial Ecosystem (SHIME). Int. J. Food Microbiol. 46: 71–79.
   PubMed Web of Science ®Google Scholar
• De Boever, P., Deplancke, B., Verstraete, W. (2000). Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem is improved by supplementing a soygerm powder. Journal of Nutrition 130: 2599–2606.
   PubMed Web of Science ®Google Scholar